Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Ruhwald

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Ebiomedicine|November 12, 2020
Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteriaJan Heyckendorf, Stephen H Gillespie, Morten Ruhwald
Health Science Reports|May 7, 2020
How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriersLena Faust, Morten Ruhwald, Samuel Schumacher, et al.
BMJ Open|December 6, 2012
Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-upTamara Tuuminen, Eeva Salo, Hannele Kotilainen, et al.
Expert Review of Vaccines|April 15, 2016
Design of tuberculosis vaccine trials under financial constraintsAlberto L García-Basteiro, Morten Ruhwald, Christoph Lange
American Journal of Respiratory and Critical Care Medicine|June 19, 2014
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosisJan Heyckendorf, Ioana D Olaru, Morten Ruhwald, et al.
Tuberculosis (Edinburgh, Scotland)|July 30, 2016
TB vaccines in clinical developmentAnn M Ginsberg, Morten Ruhwald, Helen Mearns, et al.
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Pediatric Tuberculosis Diagnostics: Present and FutureFrancesca Wanda Basile, Pamela Nabeta, Morten Ruhwald, et al.
The European Respiratory Journal|May 6, 2014
6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in DenmarkChristian Soborg, Morten Ruhwald, Peter H Andersen, et al.
Plos One|August 1, 2018
Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mailBastian Neesgaard, Morten Ruhwald, Henrik B Krarup, et al.
The Lancet. Digital Health|February 24, 2023
AI-CAD for tuberculosis and other global high-burden diseasesMatthew Arentz, Nikhil Jagtiani, Sandra Kik, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Ebiomedicine|November 12, 2020
Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteriaJan Heyckendorf, Stephen H Gillespie, Morten Ruhwald
Health Science Reports|May 7, 2020
How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriersLena Faust, Morten Ruhwald, Samuel Schumacher, et al.
BMJ Open|December 6, 2012
Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-upTamara Tuuminen, Eeva Salo, Hannele Kotilainen, et al.
Expert Review of Vaccines|April 15, 2016
Design of tuberculosis vaccine trials under financial constraintsAlberto L García-Basteiro, Morten Ruhwald, Christoph Lange
American Journal of Respiratory and Critical Care Medicine|June 19, 2014
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosisJan Heyckendorf, Ioana D Olaru, Morten Ruhwald, et al.
Tuberculosis (Edinburgh, Scotland)|July 30, 2016
TB vaccines in clinical developmentAnn M Ginsberg, Morten Ruhwald, Helen Mearns, et al.
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Pediatric Tuberculosis Diagnostics: Present and FutureFrancesca Wanda Basile, Pamela Nabeta, Morten Ruhwald, et al.
The European Respiratory Journal|May 6, 2014
6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in DenmarkChristian Soborg, Morten Ruhwald, Peter H Andersen, et al.
Plos One|August 1, 2018
Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mailBastian Neesgaard, Morten Ruhwald, Henrik B Krarup, et al.
The Lancet. Digital Health|February 24, 2023
AI-CAD for tuberculosis and other global high-burden diseasesMatthew Arentz, Nikhil Jagtiani, Sandra Kik, et al.
Pageof 17